Novo integrated sciences reports record revenue of $13.8 million in fiscal 2022 third quarter

Bellevue, wash.--(business wire)---- $nvos #aapi--novo integrated sciences, inc. (nasdaq: nvos) (the “company” or “novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation, today reported its financial results for the fiscal third quarter ended may 31, 2022. robert mattacchione, novo's ceo and board chairman, stated, “novo achieved record revenue in the fiscal 202
NVOS Ratings Summary
NVOS Quant Ranking